Oral Isotretinoin and Covid-19 Infection V1
Research type
Research Study
Full title
Does oral isotretinoin increase the risk of developing infection with and complications from Covid-19, compared to an age-matched background population.
IRAS ID
290908
Contact name
Alexandra Bonsall
Contact email
Sponsor organisation
University of Aberdeen and NHS Grampian
Duration of Study in the UK
0 years, 7 months, 14 days
Research summary
There is a theoretical risk that the nasal mucosal dryness caused by oral retinoid medications may increase the risk of patients becoming infected with Covid-19. In March 2020 we established a database of our patients on oral retinoid medications. We will now examine those patient records to identify whether, in comparison to a population with similar characteristics who were not taking oral isotretinoin, 1. patients on isotretinoin had a different rate of Covid-19 infection, 2. patients were admitted to hospital more or less frequently, 3. patients were admitted to ITU more or less frequently, 4. whether death occurred more or less frequently.
REC name
North of Scotland Research Ethics Committee 2
REC reference
21/NS/0001
Date of REC Opinion
18 Jan 2021
REC opinion
Favourable Opinion